EUVIMEDOpdag EUVIMED
Crossref

Does Neoadjuvant Chemotherapy Increase Reconstructive Risk? A Comparative Analysis of Surgical Efficiency and Microvascular Success in Advanced OSCC

Erhöht neoadjuvante Chemotherapie das rekonstruktive Risiko? Vergleich von chirurgischer Effizienz und mikrovaskulärem Erfolg bei fortgeschrittenem OSCC

Esmat Najjar, Morad Abdelraziq, Dan Yaniv, Amii Ritter iD, Imad Abu-Elnaaj, Yasmin Ghantous iD

Head & Neck · 2026-11-04

DOI: 10.1002/hed.70534 ↗

Auf einen Blick

Bei 86 Patient:innen mit komplexer Lappenrekonstruktion war neoadjuvante Chemotherapie mit kürzerer Ischämie- und OP-Zeit verbunden. Leichte Wundkomplikationen traten häufiger auf; die Gesamtrate war vergleichbar.

Fragestellung

Welchen Einfluss hat neoadjuvante Chemotherapie auf chirurgische Effizienz und postoperative Morbidität bei komplexer freier Lappenrekonstruktion bei fortgeschrittenem OSCC?

Methode

Retrospektive Vergleichsstudie bei 86 Patient:innen mit mikro-vaskulärem freiem Gewebetransfer; Vergleich NACT-Kohorte mit primärer Operation.

Ergebnisse

NACT: 39,0 ± 7,5 vs. 52,5 ± 17,9 min Ischämiezeit und 7,5 ± 0,8 vs. 8,6 ± 1,3 h OP-Dauer; jeweils p = 0,001. Gesamtkomplikationen 35 % vs. 33,3 %. Leichte Wundkomplikationen 30 % vs. 4,5 %; p = 0,004.

Einschränkungen

Für major flap failure und vaskuläre Re-Exploration war die Studie unterpowert.

Schlussfolgerung der Autor:innen

Es wurden keine statistisch signifikanten Unterschiede bei major flap failure oder vaskulärer Re-Exploration gefunden. NACT beeinträchtigt die Weichteilwundheilung, schließt eine erfolgreiche mikrovaskuläre Rekonstruktion aber nicht aus.

Kernaussagen

  • Kürzere Ischämiezeit unter NACT
  • Leichte Wundkomplikationen häufiger unter NACT
  • Keine Unterschiede bei major flap failure oder Re-Exploration

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

At a glance

Journal article in Head & Neck, published online on 2026-11-04. Written by Esmat Najjar and 5 co-authors. Institution: Department of Otorhinolaryngology-Head and Neck Surgery, Rabin Medical Center, Petah-Tikva, Israel. 23 references.

Auf einen BlickAbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Objective

To investigate the effect of neoadjuvant chemotherapy (NACT) by evaluating its impact on surgical efficiency and postoperative morbidity in patients undergoing complex free‐flap reconstruction for advanced oral cavity squamous cell carcinoma (OSCC).

Methods

A retrospective comparative study was conducted on 86 patients (NACT cohort: n = 20; Primary Surgery cohort: n = 66) undergoing microvascular free tissue transfer. Primary outcomes included surgical efficiency (ischemic time, total operative duration) and postoperative complications (major microvascular events vs. minor wound issues) that were evaluated.

Results

The NACT group presented with significantly more advanced disease (100% Stage IV vs. 39.4%; p < 0.001). Despite this higher tumor burden, the NACT cohort demonstrated significantly shorter mean ischemic times (39.0 ± 7.5 vs. 52.5 ± 17.9 min; p = 0.001) and reduced operative durations (7.5 ± 0.8 vs. 8.6 ± 1.3 h; p = 0.001). Total complication rates were comparable (35% vs. 33.3%). However, minor wound‐related complications were significantly more frequent in the NACT group (30% vs. 4.5%; p = 0.004). The flap salvage rate following re‐exploration was high and comparable between groups (80.0% vs. 85.7%).

Conclusion

No statistically significant differences were detected in major flap failure or vascular re‐exploration, though the study was underpowered to establish definitive safety equivalence for these endpoints. In exploratory subgroup analysis of RFFF reconstructions, NACT was associated with reduced ischemic time ( p = 0.017). These findings suggest that while NACT compromises soft‐tissue wound healing, it does not preclude successful microvascular reconstruction when managed with appropriate perioperative care.

Subjects

Author keywords

free‐tissue transferhead and neck carcinomamicrovascular reconstructionneoadjuvant chemotherapysurgical efficiencywound complications

Authors and institutions

  • Department of Otorhinolaryngology-Head and Neck Surgery, Rabin Medical Center, Petah-Tikva, Israel.
  • Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Department of Oral and Maxillofacial Surgery, Baruch Padeh Medical Center, Poriya, Israel.
  • The Azrieli Faculty of Medicine, Bar-Illan University, Ramat Gan, Israel.

ORCID profiles: Amii Ritter, Yasmin Ghantous

Cite

APA

Najjar, E., Abdelraziq, M., Yaniv, D., Ritter, A., Abu-Elnaaj, I., & Ghantous, Y. (2026). Does Neoadjuvant Chemotherapy Increase Reconstructive Risk? A Comparative Analysis of Surgical Efficiency and Microvascular Success in Advanced OSCC. Head & Neck. https://doi.org/10.1002/hed.70534

Vancouver

Najjar E, Abdelraziq M, Yaniv D, Ritter A, Abu-Elnaaj I, Ghantous Y. Does Neoadjuvant Chemotherapy Increase Reconstructive Risk? A Comparative Analysis of Surgical Efficiency and Microvascular Success in Advanced OSCC. Head & Neck. 2026. doi:10.1002/hed.70534

BibTeX
@article{Najjar2026,
  author = {Najjar, Esmat and Abdelraziq, Morad and Yaniv, Dan and Ritter, Amii and Abu-Elnaaj, Imad and Ghantous, Yasmin},
  title = {Does Neoadjuvant Chemotherapy Increase Reconstructive Risk? A Comparative Analysis of Surgical Efficiency and Microvascular Success in Advanced OSCC},
  journal = {Head & Neck},
  year = {2026},
  doi = {10.1002/hed.70534}
}
Start for free →